Method for three-volume differential determination of lymphocyte, monocyte and granulocyte populations of leukocytes

• US 4,485,175 A
• Filed: 01/03/1983
• Issued: 11/27/1984
• Est. Priority Date: 01/03/1983
• Status: Expired due to Term

• Current Assignee: Coulter International Corp. (Danaher Corporation)
• Original Assignee: Coulter Electronics, Inc. (Danaher Corporation)
• Inventors: Crews, Harold R., Ledis, Stephen L., Sena, Ted, Carter, James H. II
• Primary Examiner(s): Turk, Arnold
• Application Number:
  US06/454,926
• Time in Patent Office: 694 Days
• Field of Search: 436/63, 436/10, 436/17
• US Class Current: 436/63
• CPC Class Codes: G01N 15/131 Details G01N15/13 takes precedence
• CPC Class Codes: G01N 33/5094 for blood cell populations red blood cells G01N33/80
• CPC Class Codes: Y10T 436/101666 Particle count or volume standard or control [e.g., platelet count standards, etc.]
• CPC Class Codes: Y10T 436/107497 Preparation composition [e.g., lysing or precipitation, etc.]

Abstract

A method and reagent system is described for differential determination of three-populations of leukocytes (lymphocyte, monocyte and granulocyte), using an automatic counting system. The reagent system includes a blood diluent and lysing reagent. The blood diluent is an osmotically balanced aqueous solution of ingredients at a preselected pH for maintaining erythrocyte morphology, blood cell stabilizing, buffering and bacteriostatic action. The lysing reagent is a mixture of an aqueous solution of quaternary ammonium salts, which lysing reagent is added to the diluted blood under more mild conditions of concentration and at a slower rate than is current practice in order to obtain an unexpected volumetric modification of at least one of the three-populations of leukocytes, whereby volumetric differential analysis can be accomplished.

Claims

1. A method for the volumetric differentiation of leukocytes into at least two populations which are identified as monocytes and granulocytes, respectively, from a whole blood sample, using an automatic particle analyzing system, said method comprising the steps of:

I. supplying, for use by the analyzing system for its mixing and analyzing, the whole blood sample and a volume of an isotonically balanced blood diluent; and

II. mixing the whole blood sample and the diluent by the analyzing system with a therein supplied lysing reagent in such a manner that the lysing reagent is at a significantly weak concentration and is supplied at a significantly slow rate, so as to subject the leukocytes to a low gradient of lytic shock, so as to result in the volumetric modification of the individual blood cells of at least one of the populations of leukocytes for a significant period of time to thereby enable the automatic differentiation of the leukocyte populations by the analyzing system;

the lysing reagent comprising a mixture of an aqueous solution of quaternary ammonium salts having surface acting properties.

2. The method of claim 1 wherein the ratio of whole blood to active lytic ingredients in said lysing reagent approximate the ratio of 1 uL:

1.4 mg.

3. The method of claim 1 in which said steps of supplying and mixing are accomplished in such a manner that the blood cell volume modification causes the granulocyte population to acquire a volume distribution of larger volume than that of the monocyte population.

4. The method of claim 1 further including the step of, at least one of, counting and classifying the differentiated populations.

5. The method of claim 1 wherein the whole blood sample is at least partially diluted with the blood diluent before mixing with the lysing reagent.

6. The method of claim 1 wherein the lysing reagent is at least partially diluted with the blood diluent before mixing with the whole blood sample.

7. The method of claim 1 wherein the lysing reagent further comprises means for forming a suitable chromagen for hemoglobin determination.

8. The method of claim 7 wherein said chromagen forming means is an alkali metal cyanide.

9. The method of claim 1 wherein said quaternary ammonium salts are a mixture of dodecyltrimethylammonium chloride and hexadecyltrimethylammonium bromide.

10. The method of claim 9 wherein said dodecyltrimethylammonium chloride and said hexadecyltrimethylammonium bromide measured in grams per liter are present in the approximate ratio of 13±

6;

1.

11. The method of claim 1 wherein said quaternary ammonium salts are a mixture of dodecyltrimethylammonium chloride and dimethylethylhexadecylammonium bromide.

12. The method of claim 11 wherein said dodecyltrimethylammonium chloride and said dimethylethylhexadecylammonium bromide measured in grams per liter, are present in the approximate ratio of 14±

6;

1.

13. The method of claim 1 wherein the whole blood sample contains lymphocytes, and the volumetric modification of the blood cells enables three population differentiation.

14. The method of claim 13 wherein the volumetric modification of the blood cells causes the monocyte population to be positioned volumetrically between the lymphocyte and granulocyte populations.

15. The method of claim 1 wherein the diluent comprises a mixture of:

(1) buffering means, (2) cell membrane stabilizing means, and (3) germicidal means;

the end volume concentration and total amount of which serve to slow the lysing kinetics upon at least one of the leukocyte populations.

16. The method of claim 15 wherein said buffering means is N-(1-acetamido)iminodiacetic acid (ADA);

said cell stabilizing means is Procaine hydrochloride; and

said germicidal means is dimethylolurea.

17. The method of claim 15 wherein said diluent has a pH of about 7.0±

0.4 and an osmolality of about 320±

50 mOs/kg.

18. The method of claim 1 wherein said quaternary ammonium salts are a mixture of dodecyltrimethylammonium chloride and tetradecyltrimethylammonium bromide.

19. The method of claim 18 wherein said dodecyltrimethylammonium chloride is present in a concentration range of 20 to 55 g/L and said tetradecyltrimethylammonium bromide is present in a concentration of 2 to 6 g/L.

20. The method of claim 18 wherein said dodecyltrimethylammonium chloride and said tetradecyltrimethylammonium bromide measured in grams per liter, are present in the approximate ratio of 9.5±

4;

1.

21. A method for the volumetric differentiation of at least the monocyte and granulocyte populations obtained from a whole blood sample, said method comprising the steps of:

supplying and mixing the whole blood sample and a lysing reagent, the lysing reagent is at a significantly weak concentration and is supplied at a significantly slow rate so as to result in a low gradient of lytic shock and thereby the volumetric modification of the individual blood cells of at least one of the populations of monocytes and granulocytes for a significant period of time to thereby enable the volumetric differentiation of these populations.